Avakine

Avakine

Remicade®, see there.
Mentioned in ?
References in periodicals archive ?
The Plaintiffs have alleged that Defendants made false and misleading public statements concerning the signing of an European marketing partner for Remicade, formerly known as Avakine, in the fourth quarter of 1997 and its corresponding positive effect on the financial results of the Company, which artificially inflated the market price of the common stock during the Class Period and caused damage to Plaintiffs and the Class, in violation of the Securities Exchange Act of 1934.